MedVital, a medtech startup focused on wound care and regenerative aesthetics, has raised ₹18 crore (approximately $1.89 million) in a growth funding round led by Alkemi Growth Capital.
The round also saw participation from Sanjay Arora, Shubhan Ventures, along with existing investors. The company had earlier raised capital from 4point0 Health Ventures and other angel investors.
Founded in 2024, MedVital is building medical technologies across advanced wound care, regenerative aesthetics, and chronic skin conditions. The company plans to use the fresh capital to expand its operations, accelerate product development, and strengthen its capabilities across devices, biomaterials, and biologics.
MedVital currently operates in the advanced wound care segment through its NoWound portfolio, which includes negative pressure wound therapy systems and liquid bandage solutions designed for hospital use. According to the company, its products have already been adopted by more than 200 healthcare institutions across India, with strong repeat usage from hospitals.
In addition to wound care, the startup has also launched Elyara, a product line focused on non-invasive solutions for skin and hair restoration, marking its entry into the regenerative aesthetics space.
With rising demand for advanced healthcare solutions and minimally invasive treatments, MedVital is positioning itself at the intersection of medical technology and aesthetics, aiming to build a comprehensive portfolio across multiple healthcare segments.
-By Shivani Solanki
